A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer
NCT00251472
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Paclitaxel Albumin Nanoparticle for Injectable Suspension
Sponsor
Veeda Oncology
Collaborators
[object Object]